Publication list of the last 5 years, dr

Publication list of the last 5 years, Dr. Gerhard Laux

Schlee M, Schuhmacher M, Hölzel M, Laux G and Bornkamm G W. c-MYC
Impairs Immunogenicity of Human B Cells Adv. Cancer Res. 97: 167-188,
2007.
Schlee M, Hölzel M, Bernard S, Mailhammer R, Schuhmacher M, Reschke J,
Eick D, Marinkovic D, Wirth T, Rosenwald A, Staudt L M, Eilers M, Baran-
Marszak F, Fagard R, Feuillard J, Laux G and Bornkamm G W. c-MYC
activation impairs the NF-κB and the interferon response in conditional B cell
systems: implications for the pathogenesis of Burkitt’s lymphoma. Int. J.
Cancer
120: 1387-1395, 2007.
Bornkamm G W, Berens C, Kuklik-Roos C, Bechet J M, Laux G, Bachl J,
Korndoerfer M, Schlee M, Holzel M, Malamoussi A, Chapman R D, Nimmerjahn
F, Mautner J, Hillen W, Bujard H and Feuillard J. Stringent doxycycline-
dependent control of gene activities using an episomal one-vector system.
Nucleic Acids Res. 33: e137, 2005.
Dudziak D, Nimmerjahn F, Bornkamm G W and Laux G. Alternative splicing
generates soluble CD83 proteins that inhibit T cell proliferation. J. Immunol.
174: 6672-6676, 2005.
Pagès F, Galon J, Karaschuk G, Dudziak D, Camus M, Lazar V, Camilleri-Broët
S, Lagorce-Pagès C, Lebel-Binay S, Laux G, Fridman W-H and Henglein B.
Epstein-Barr Virus Nuclear Antigen 2 Induces Interleukin-18 Receptor
Expression in B-cells. Blood 105: 1632-1639, 2005.

Schlee M, Krug T, Gires O, Zeidler R, Hammerschmidt W, Mailhammer R, Laux
G, Sauer G, Lovric J and Bornkamm G W. Identification of Epstein-Barr Virus
(EBV) Nuclear Antigen 2 (EBNA2) Target Proteins by Proteome Analysis:
Activation of EBNA2 in Conditionally Immortalized B Cells Reflects Early
Events after Infection of Primary B Cells by EBV. J. Virol. 78: 3941-3952,
2004.
Dudziak D, Kieser A, Dirmeier U, Nimmerjahn F, Berchtold S, Steinkasserer A,
Marschall G, Hammerschmidt W, Laux G and Bornkamm G W. The latent
membrane proteine 1 of Epstein-Barr virus induces CD83 by the NF-κB
signalling pathway. J. Virol. 77: 8290-8298, 2003.
Moreno S, Laux G, Brielmeier M, Bornkamm G W and Conrad M. Testis-
specific expression of the nuclear form of phospholipid hydroperoxide
glutathione peroxidase (PHGPx). Biol. Chem. 384: 635-643, 2003.

Ten most important publications older than 5 years, Dr. Gerhard Laux

Pajic A, Polack A, Staege M S, Spitkovsky D, Baier B, Bornkamm G W and
Laux G. Elevated expression of c-myc in lymphoblastoid cells does not support
an Epstein-Barr virus latency III-to-I switch. J. Gen. Virol. 82: 3051-3055,
2001.

Kaiser C, Laux G, Eick D, Jochner N, Bornkamm G W and Kempkes B. The
proto-oncogene c-myc is a direct target gene of Epstein-Barr virus nuclear
antigen 2. J. Virol. 73: 4481-4484, 1999.
Brielmeier M, Mautner J, Laux G and Hammerschmidt W. The latent
membrane protein 2 gene of Epstein-Barr virus is important for efficient B cell
immortalization. J. Gen. Virol. 77: 2807-2818, 1996.
Laux G, Adam B, Strobl L J and Moreau-Gachelin F. The Spi-1/PU.1 and Spi-B
ets family transcription factors and the recombination signal-binding protein
RBP-Jκ interact with an Epstein-Barr virus nuclear antigen 2 responsive cis-
element. EMBO J. 13: 5624-5632, 1994.

Laux G, Dugrillon F, Eckert C, Adam B, Zimber-Strobl U and Bornkamm G W.
Identification and characterization of an Epstein-Barr virus nuclear antigen 2-
responsive cis element in the bidirectional promoter region of latent
membrane protein and terminal protein 2 genes. J. Virol. 68: 6947-6958,
1994.
Rowe D T, Hall L, Joab I and Laux G. Identification of the Epstein-Barr virus
terminal protein (TP) gene products in latently infected lymphocytes. J. Virol.
64: 2866-2875, 1990.
Laux G, Economou A and Farrell P J. The terminal protein gene 2 of Epstein-
Barr virus is transcribed from a bidirectional latent promoter region. J. Gen.
Virol.
70: 3079-3084, 1989.
Laux G, Perricaudet M and Farrell P J. A spliced Epstein-Barr virus gene
expressed in immortalized lymphocytes is created by circularisation of the
linear viral genome. EMBO J. 7: 769-774, 1988.
Laux G, Freese U K, Fischer R, Polack A, Kofler E and Bornkamm G W. TPA
inducible Epstein-Barr virus genes in Raji cells and their regulation. Virology
162: 503-507, 1988.
Laux G, Freese U K and Bornkamm G W. Structure and evolution of two
related transcription units of Epstein-Barr virus carrying small tandem
repeats. J. Virol. 56: 987-995, 1985.

Source: http://www.helmholtz-muenchen.de/fileadmin/KMOLBI/PDF/Strobl/pub_laux.pdf

Layout

Flyer_malamix_color_Layout 1 2/08/13 11:06 Page 1Dagelijks zie ik in de praktijk zieke vissen met een slechte slijmlaag (te weinig slijm, te dikkeslijm, slechte consistentie. .). Indien de slijmlaag te weinig afweerstoffen bevat, is de kans groterdat uw vis ziek wordt. In elke vijver zijn er immers steeds ziekteverwekkers aanwezig, die bijzwakkere vissen makkelijker de bovenhand nemen. Een gez

silanes.com.mx

Laboratorios Silanes, S.A. de C.V. Información para prescribir 84593 SSA-II ALBORAL* Solución Inyectable EEAR 06330022070291/RM2007 INFORMACION PARA PRESCRIBIR AMPLIA IPP-A A L B O R A L* FORMA FARMACEUTICA Y FORMULACION Cada ampolleta contiene: Diazepam . 10 mg Vehículo cbp. 2 mL INDICACIONES TERAPEUTICAS ALBORAL* es un medicamento psicótropo con

Copyright ©2018 Sedative Dosing Pdf